Zyla Life Sciences Debt Issuance Costs, Net
Zyla Life Sciences had Debt Issuance Costs, Net of $719.00 thousand as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Notes › Debt › Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
us-gaap:DeferredFinanceCostsNet · last filed 2020-05-14
- 2020-03-31: Debt Issuance Costs, Net $719.00K.
- 2019-12-31: Debt Issuance Costs, Net $792.00K.
- 2019-09-30: Debt Issuance Costs, Net $864.00K.
- 2019-06-30: Debt Issuance Costs, Net $862.00K.
| Period end | Debt Issuance Costs, Net |
|---|---|
| 2020-03-31 | $719.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $792.00K 10-Q · filed 2020-05-14 |
| 2019-09-30 | $864.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $862.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $253.00K 10-Q · filed 2019-05-17 |